fta...
Remember how HHS just bought $300 million dollars of medicine that it noisily claims is for nuclear preparedness? Specifically, BARDA said it bought Amgen’s Nplate drug, which can be used to “combat the effects of acute radiation sickness.”
But guess what ELSE Nplate treats? I checked Amgen’s website. Oddly, I didn’t find anything on the Nplate page about treating radiation sickness. But I did find THIS:
How about that, Sally? Nplate’s primary approved use is to treat “immune thrombocytopenia.”
“Immune thrombocytopenia” sounded familiar.
On a hunch, I hopped over to PubMed and searched the journals for the keywords “vaccine immune thrombocytopenia.” Guess what? It returned NINE HUNDRED AND SIX hits: